Can Informatics Drive Clinical Quality Improvements Alongside Operational Improvements in Cancer Care?

Ihealthtran

Due to the complexity of the disease biology, rapidly increasing treatment options, patient mobility, multi-disciplinary care teams, and high costs of treatment - informatics can play a more substantial role in improving outcomes and reducing the cost of cancer care. In this webinar, we will review how tumor board solutions, precision medicine frameworks, and oncology pathways are being used within clinical quality programs as well as understanding their role in driving operational improvements and increasing patient retention. We will demonstrate the requirements around both interoperability and the clinical depth needed to ensure adoption and effective capture and use of information to accomplish these goals.
Watch Now

Spotlight

The cell therapy industry is actively working to simplify and close processes to optimize manufacturing, reduce costs, and increase speeds of getting treatments to patients. While viral gene delivery has been in use for quite some time, nonviral delivery methods are attractive because of their reduced cytotoxicity, immunogenicit

OTHER ON-DEMAND WEBINARS

Strategies to Access, Interpret and Get Results From Your Company's Health Care Data

Lorman

The "old fashioned way" no longer works. Most firms still operate health plans the old fashioned way without connecting the dots between plan data and predictable health risk exposures - even though studies show that over 70 percent of costly illnesses are predictable. Under the old fashioned scenario, plans are still administrated without the benefit of leading edge technology that easily measures and manages workforce health risk that is based on member engagement and automation.
Watch Now

2020 Healthcare Cybersecurity Threat Landscape

Fortinet

Healthcare organizations globally continue to be targets of sophisticated cyber threats during the COVID-19 pandemic using tactics that are evolving across patient care ecosystem. These new threats are challenging organizations to evolve and adapt their defense in depth security posture as they have continued their digital transformation to support new workflows, implement new connected clinical devices, expand telemedicine and telehealth and support a remote workforce.
Watch Now

Collaborating to Improve Health Beyond the Hospital

modern healthcare

After investing considerable effort in managing throughput, many hospitals and health systems today have created a more coordinated inpatient experience. But as hard as it is to create a harmonious environment within a hospital's walls, unifying patient care outside those walls is exponentially more difficult. NewYork-Presbyterian Hospital has adopted an innovative population health management strategy that is helping them build a better healthcare system outside the hospital, driving a transformational shift in patient care delivery.
Watch Now

The Collaborative Role of Technology and PharmD in Managing Chronic Conditions

Himsslearn

The prevalence and cost of chronic, cardiometabolic conditions like Type 2 Diabetes and Heart Disease is one of the greatest healthcare challenges we face today. Luckily, price points are coming down on cellular and Bluetooth-enabled medical devices like blood pressure cuffs and glucometers, and at the same time, enhanced interoperability capabilities are allowing us to seamlessly pull patient-generated data from the devices into analytics platforms and combine it with patient record data from the EHR. The connection gives clinicians a more complete view of their patients’ health whether at the point-of-care or virtually giving them the ability to detect costly complications before they happen, and prompting them to intervene with appropriate guideline-based management.
Watch Now

Spotlight

The cell therapy industry is actively working to simplify and close processes to optimize manufacturing, reduce costs, and increase speeds of getting treatments to patients. While viral gene delivery has been in use for quite some time, nonviral delivery methods are attractive because of their reduced cytotoxicity, immunogenicit

resources